Amdocs Limited $DOX Stock Holdings Increased by Alliancebernstein L.P.

Alliancebernstein L.P. increased its stake in shares of Amdocs Limited (NASDAQ:DOX) by 32.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,359,779 shares of the technology company’s stock after purchasing an additional 573,349 shares during the quarter. Alliancebernstein L.P. owned approximately 2.09% of Amdocs worth $193,620,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DOX. Amundi grew its holdings in shares of Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock valued at $1,217,000 after acquiring an additional 5,816 shares in the last quarter. Millennium Management LLC boosted its position in Amdocs by 458.3% during the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after purchasing an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Amdocs by 12.6% in the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock valued at $30,300,000 after purchasing an additional 37,087 shares in the last quarter. Empowered Funds LLC grew its stake in Amdocs by 12.0% in the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after purchasing an additional 1,709 shares in the last quarter. Finally, Jane Street Group LLC increased its position in Amdocs by 195.4% in the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after purchasing an additional 76,683 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on DOX. Stifel Nicolaus cut their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Barclays reduced their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Stock Performance

Shares of DOX opened at $66.64 on Tuesday. The company has a market capitalization of $7.19 billion, a PE ratio of 12.89, a price-to-earnings-growth ratio of 1.17 and a beta of 0.42. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. Amdocs Limited has a one year low of $65.39 and a one year high of $95.41. The company’s fifty day moving average price is $74.79 and its 200 day moving average price is $79.00.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the business posted $1.66 earnings per share. The firm’s revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 annualized dividend and a dividend yield of 3.4%. Amdocs’s dividend payout ratio (DPR) is presently 40.81%.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.